PT-141 (Bremelanotide)

PT-141 (Bremelanotide) is a synthetic cyclic heptapeptide supplied as a lyophilized powder for in vitro laboratory research and scientific investigation only.

• PT-141 (Bremelanotide) — $54.99 AUD

Product Description

Research Use Only

PT-141 (Bremelanotide) is a synthetic cyclic heptapeptide supplied as a lyophilized powder for in vitro laboratory research and scientific investigation only.

This compound is intended strictly for use in controlled research environments and is not approved for human or veterinary use.

Technical Specifications

Compound: PT-141 (Bremelanotide)

Peptide Length: 7 amino acids

Molecular Weight: ~1,025 g/mol

Purity: ≥99.0% (verified by Certificate of Analysis)

Appearance: White to off-white lyophilized powder

Solubility: Soluble in water (H₂O)

Quality Verification: Confirmed by RP-HPLC analysis

Storage Conditions:

Store dry at 2–8 °C

Reconstituted material should be refrigerated and used within 6 weeks

Product Disclaimer

This product is intended solely for scientific research and education

Not for use in humans or animals

Not for use in clinical trials involving humans

Not to be administered or supplied for human investigational use

This product is not a drug, food, or cosmetic

No claims are made regarding safety, efficacy, or therapeutic application

Manufactured in a GMP-compliant, ISO 9001:2008 facility.Each batch is fully analysed to ensure quality and purity and is free of LPS.

By purchasing this product, the buyer acknowledges that this compound is an investigational research material and assumes all responsibility for proper handling, storage, and use in compliance with all applicable laws and regulations.

For laboratory research only. Not for human consumption.